MedRx Co. Ltd. reported consolidated earnings results for the nine months ended September 30, 2019. For the nine months, the company reported net sales of JPY 168 million compared to JPY 8 million a year ago. Operating loss was JPY 1,209 million compared to JPY 947 million a year ago. Loss attributable to owners of parent was JPY 1,196 million or JPY 101.88 per share compared to JPY 940 million or JPY 94.71 per share a year ago.

For the year ending December 31, 2019, the company forecasts consolidated net sales of JPY 172 million, operating loss of JPY 1,866 million and loss attributable to owners of parent of JPY 1,856 million or JPY 145.99 per share.